The study of neuroprotection about erythropoietin on traumatic brain injury in rats
Wei Feng
Abstract
Wei Feng
Abstract
Objective:To explore the effectiveness of erythropoietin (EPO) administration on blood-brain barrier (BBB), brain edema, brain injury volume and NSE levels in serum after TBI in rats. Method: Experimental TBI was induced in rats by a weight-drop model. A total of 72 adult Wistar rats were divided into sham operation group (n=24), control group (n=24), EPO treatment group (n=24). Forty-eight hours after injury, extent of BBB breakdown, brain water content and injury volume were observed and 24 hours after injury neuron-specific enolase (NSE) in serum was measured. Result: BBB breakdown was lower in EPO group (67.3 ±13.1μg/g) than that in control group (182.8±15.9 μg/g, P0.01). Brain edema reduced in EPO group (80.6%±0.2%) compared with that in control group(91.8%±0.6%, P0.01). EPO treatment (17.9±4.0mm3) reduced brain injury volume compared with that in control group(37.7±3.8mm3, P0.01).NSE levels in serum was lower in EPO group(6.28±3.37ng/ml) than that in control group (10.02±1.50ng/ml,P0.05). Conclusion:Administration of EPO can keep the integrity of BBB, and reduce brain injury volume, brain edema and neuron damage.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To explore the effectiveness of erythropoietin (EPO) administration on blood-brain barrier (BBB), brain edema, brain injury volume and NSE levels in serum after TBI in rats. Method: Experimental TBI was induced in rats by a weight-drop model. A total of 72 adult Wistar rats were divided into sham operation group (n=24), control group (n=24), EPO treatment group (n=24). Forty-eight hours after injury, extent of BBB breakdown, brain water content and injury volume were observed and 24 hours after injury neuron-specific enolase (NSE) in serum was measured. Result: BBB breakdown was lower in EPO group (67.3 ±13.1μg/g) than that in control group (182.8±15.9 μg/g, P0.01). Brain edema reduced in EPO group (80.6%±0.2%) compared with that in control group(91.8%±0.6%, P0.01). EPO treatment (17.9±4.0mm3) reduced brain injury volume compared with that in control group(37.7±3.8mm3, P0.01).NSE levels in serum was lower in EPO group(6.28±3.37ng/ml) than that in control group (10.02±1.50ng/ml,P0.05). Conclusion:Administration of EPO can keep the integrity of BBB, and reduce brain injury volume, brain edema and neuron damage.
Key concepts: Enolase, Erythropoietin, Brain edema, Traumatic brain injury, Medicine, Neuroprotection, Edema, Anesthesia